Pregnancy and neonatal outcomes after periconceptional exposure to isotretinoin in Koreans

• Príomhchruthaitheoirí: Eun-Hwan Cha (Údar), NaeRy Kim (Údar), Ho-Seok Kwak (Údar), Hae Ji Han (Údar), Sung Hong Joo (Údar), June-Seek Choi (Údar), Kyoung-Chul Chun (Údar), Young-Ah Kim (Údar), Jae-Whoan Koh (Údar), Jung Yeol Han (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Korean Society of Obstetrics and Gynecology, 2022-03-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Objective Isotretinoin should not be used during pregnancy because of the risk of birth defects. Most pregnant women exposed to isotretinoin choose voluntary pregnancy termination due to concerns about birth defects. However, birth outcome data supporting the termination of pregnancy are lacking. Th...